Skip to main content

Attention-Deficit Hyperactivity Disorder (ADHD)

Mental Health

Attention-Deficit Hyperactivity Disorder (ADHD) is treated with 26 medications in our database, including Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate, Lisdexamfetamine Dimesylate, Methylphenidate Hydrochloride, Atomoxetine, MYDAYIS, and 21 more. 17 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Teva Pharmaceuticals, Takeda, Novartis, Eli Lilly, Arbor and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Attention-Deficit Hyperactivity Disorder (ADHD) treatment below.

What help exists for Attention-Deficit Hyperactivity Disorder (ADHD)

23

drugs indexed

6

with copay cards

7

with patient assistance

0

open travel grants

Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.

Drugs used to treat Attention-Deficit Hyperactivity Disorder (ADHD)

23 total

🎟 = copay card Β· πŸ’™ = patient assistance program

Prior authorization patterns for Attention-Deficit Hyperactivity Disorder (ADHD) drugs

Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.

PayerPAStep therapyCopay tier

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

Showing 10 of 25 PA rules for Attention-Deficit Hyperactivity Disorder (ADHD) drugs. View individual drug pages for complete PA detail.